Hypercoagulability in COVID-19: from an unknown beginning to future therapies

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global public health concern and is characterized by an exaggerated inflammatory response that can lead to a large variety of clinical manifestations such as respiratory distress, se...

Descripción completa

Detalles Bibliográficos
Autores principales: Duca, Ştefania-Teodora, Costache, Alexandru-Dan, Miftode, Radu-Ştefan, Mitu, Ovidiu, PetriŞ, Antoniu-Octavian, Costache, Irina-Iuliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387574/
https://www.ncbi.nlm.nih.gov/pubmed/36060499
http://dx.doi.org/10.15386/mpr-2195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387574/
https://www.ncbi.nlm.nih.gov/pubmed/36060499
http://dx.doi.org/10.15386/mpr-2195

Ejemplares similares